Le. Lantry et al., Effect of farnesyltransferase inhibitor FTI-276 on established lung adenomas from A/J mice induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, CARCINOGENE, 21(1), 2000, pp. 113-116
The Ras protein undergoes a series of post-translational modifications at t
he C-terminal CAAX motif, which culminates with the anchoring of p21 Ras to
the plasma membrane where it relays growth regulatory signals from recepto
r tyrosine kinases to various pathways of cell signal transduction, FTI-276
is a CAAX peptidomimetic of the carboxyl terminal of Ras proteins. Pharmac
okinetic analysis of FTI-276 in A/J mice with a time-release pellet system
showed a dose of 50 mg/kg body wt achieved an average serum level of 1.68 m
u g/ml for up to 30 days following implantation, In the present study, 4 we
ek old A/J mice were initiated with a single dose of 4-(methylnitrosamino)-
1-(3-pyridyl)-1-butanone (100 mg/kg), and monitored for 18 weeks, Mice were
grouped for daily delivery (time-release pellet) of 50 mg/kg of FTI-276 fo
r 30 days (n = 12) and the control group (n = 12), Analysis of tumors from
time-release pellet treated animals showed a 60% reduction in tumor multipl
icity and a 42% reduction in tumor incidence. Moreover, FTI-276 treatment r
esulted in a significant reduction in tumor volume (similar to 58%), Mutati
on analysis of the lung tumors from both treatment groups revealed that mos
t of the tumors harbored mutations in the codon 12 of K-ras and there is no
significant difference in the incidence and types of mutations between tum
ors from the treated and control animals. This is the first demonstration o
f chemotherapeutic efficacy of a synthetic CAAX peptidomimetie farnesyltran
sferase inhibitor in a primary lung tumor model.